London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

AIM modelling company raises £450,000 at a steep discount, betting that investment in growth will justify near-term pain for ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

(Alliance News) - Physiomics PLC on Monday saw its shares decline as it posted a widened interim loss, but expressed optimism on hitting market expectations for the full-year. Oxford, England-based ...

Shares in Physiomics PLC (PYC.LN) soared on Thursday, prompting the company to clarify the value of its recently announced contract with Merck KGaA (MRK.XE). On Nov. 28, Physiomics said that it had ...

Jim Millen has been the CEO of Physiomics Plc (LON:PYC) since 2016, and this article will examine the executive's compensation with respect to the overall performance of the company. This analysis ...

New Agreement to optimise oncology combination with top five pharma company. Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a new ...

Physiomics (GB:PYC) has released an update. Physiomics PLC has partnered with DoseMe to integrate its personalized dosing software into the DoseMeRx platform, enhancing precision in chemotherapy and ...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to ...

Investors with a long-term horizong may find it valuable to assess Physiomics Plc’s (AIM:PYC) earnings trend over time and against its industry benchmark as opposed to simply looking at a sincle ...

Oxford-based biology systems business Physiomics has signed a substantial contract with a global pharmaceutical company. Physiomics will determine the optimal dosing regimen of a new compound ...

UK-based systems biology company Physiomics has entered into a 4.0m pound standby equity distribution agreement with YA Global Master SPV, an investment fund managed by Yorkville Advisors. The ...